Certified by Founder Lodge
Sands Capital
United States - Arlington, VA
INVESTOR
1 Disclosed Funding Rounds $223,000,000
12 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Sands Capital is an active, long-term investor in leading innovative businesses globally. Our approach combines analytical rigor and creative thinking to seek to identify high-quality growth
Company | Date | Round | Raised |
---|---|---|---|
Cleerly | July, 25 ,2022 | Series C | $223,000,000 |
HAWK:AI | January, 27 ,2023 | Series B | $17,000,000 |
Papercup | June, 09 ,2022 | Series A | $20,000,000 |
Selux Diagnostics, Inc | March, 01 ,2022 | Series C | $50,000,000 |
HUNGRY | June, 26 ,2023 | Series C | $10,000,000 |
OneTrust | July, 25 ,2023 | Unknown | $150,000,000 |
Beta Bionics | September, 04 ,2023 | Series D | $100,000,000 |
SafeRide Health | October, 06 ,2023 | Series C | |
Cytovale | November, 16 ,2023 | Series C | $84,000,000 |
Elephas | January, 24 ,2024 | Series C | $55,000,000 |
Alamar Biosciences, Inc. | February, 27 ,2024 | Series C | $128,000,000 |
Credo AI | July, 31 ,2024 | Unknown | $21,000,000 |